Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.
Andrigo Barboza De NardiRodrigo Dos Santos HortaCarlos Eduardo Fonseca AlvesFelipe Noleto de PaivaLaís Calazans Menescal LinharesBruna Fernanda FirmoFelipe Augusto Ruiz SueiroKrishna Duro de OliveiraSilvia Vanessa LourençoRicardo De Francisco StrefezziCarlos Henrique Maciel BrunnerMarcelo Monte Mor RangelPaulo Cesar JarkJorge Luiz Costa CastroRodrigo UbukataKaren BatschinskiRenata Afonso SobralNatália Oyafuso da CruzAdriana Tomoko NishiyaSimone Crestoni FernandesSimone Carvalho Dos Santos CunhaDaniel Guimarães GerardiGuilherme Sellera Godoy ChalloubLuiz Roberto BiondiRenée Laufer AmorimPaulo Ricardo de Oliveira PaesGleidice Eunice LavalleRafael Ricardo HuppesFabrizio GrandiCarmen Helena de Carvalho VasconcellosDenner Santos Dos AnjosÂngela Cristina Malheiros LuzoJulia Maria MateraMiluse VozdovaMaria Lucia Zaidan DagliPublished in: Cells (2022)
Mast cell tumors (MCTs) are hematopoietic neoplasms composed of mast cells. It is highly common in dogs and is extremely important in the veterinary oncology field. It represents the third most common tumor subtype, and is the most common malignant skin tumor in dogs, corresponding to 11% of skin cancer cases. The objective of this critical review was to present the report of the 2nd Consensus meeting on the Diagnosis, Prognosis, and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors, which was organized by the Brazilian Association of Veterinary Oncology (ABROVET) in August 2021. The most recent information on cutaneous and subcutaneous mast cell tumors in dogs is presented and discussed.